435 related articles for article (PubMed ID: 18606742)
21. Dominant expression of androgen receptors and their functional regulation of organic anion transporter 3 in rat brain capillary endothelial cells; comparison of gene expression between the blood-brain and -retinal barriers.
Ohtsuki S; Tomi M; Hata T; Nagai Y; Hori S; Mori S; Hosoya K; Terasaki T
J Cell Physiol; 2005 Sep; 204(3):896-900. PubMed ID: 15795901
[TBL] [Abstract][Full Text] [Related]
22. Drug-drug interaction between oxycodone and adjuvant analgesics in blood-brain barrier transport and antinociceptive effect.
Nakazawa Y; Okura T; Shimomura K; Terasaki T; Deguchi Y
J Pharm Sci; 2010 Jan; 99(1):467-74. PubMed ID: 19499573
[TBL] [Abstract][Full Text] [Related]
23. A proton-coupled organic cation antiporter is involved in the blood-brain barrier transport of Aconitum alkaloids.
Cong J; Ruan Y; Lyu Q; Qin X; Qi X; Liu W; Kang L; Zhang J; Wu C
J Ethnopharmacol; 2020 Apr; 252():112581. PubMed ID: 31968215
[TBL] [Abstract][Full Text] [Related]
24. Carrier-Mediated Transport of Nicotine Across the Inner Blood-Retinal Barrier: Involvement of a Novel Organic Cation Transporter Driven by an Outward H(+) Gradient.
Tega Y; Kubo Y; Yuzurihara C; Akanuma S; Hosoya K
J Pharm Sci; 2015 Sep; 104(9):3069-75. PubMed ID: 25892000
[TBL] [Abstract][Full Text] [Related]
25. Memantine transport across the mouse blood-brain barrier is mediated by a cationic influx H+ antiporter.
Mehta DC; Short JL; Nicolazzo JA
Mol Pharm; 2013 Dec; 10(12):4491-8. PubMed ID: 24098999
[TBL] [Abstract][Full Text] [Related]
26. Involvement of the H+/organic cation antiporter in nicotine transport in rat liver.
Tega Y; Akanuma S; Kubo Y; Hosoya K
Drug Metab Dispos; 2015 Jan; 43(1):89-92. PubMed ID: 25352656
[TBL] [Abstract][Full Text] [Related]
27. Studies on functional sites of organic cation/carnitine transporter OCTN2 (SLC22A5) using a Ser467Cys mutant protein.
Ohashi R; Tamai I; Inano A; Katsura M; Sai Y; Nezu J; Tsuji A
J Pharmacol Exp Ther; 2002 Sep; 302(3):1286-94. PubMed ID: 12183691
[TBL] [Abstract][Full Text] [Related]
28. Expression and localization of carnitine/organic cation transporter OCTN1 and OCTN2 in ocular epithelium.
Garrett Q; Xu S; Simmons PA; Vehige J; Flanagan JL; Willcox MD
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4844-9. PubMed ID: 18641280
[TBL] [Abstract][Full Text] [Related]
29. Probing the substrate specificity of the ergothioneine transporter with methimazole, hercynine, and organic cations.
Grigat S; Harlfinger S; Pal S; Striebinger R; Golz S; Geerts A; Lazar A; Schömig E; Gründemann D
Biochem Pharmacol; 2007 Jul; 74(2):309-16. PubMed ID: 17532304
[TBL] [Abstract][Full Text] [Related]
30. Cationic amino acid transporter 1-mediated L-arginine transport at the inner blood-retinal barrier.
Tomi M; Kitade N; Hirose S; Yokota N; Akanuma S; Tachikawa M; Hosoya K
J Neurochem; 2009 Nov; 111(3):716-25. PubMed ID: 19712052
[TBL] [Abstract][Full Text] [Related]
31. OCTN2-mediated transport of carnitine in isolated Sertoli cells.
Kobayashi D; Goto A; Maeda T; Nezu J; Tsuji A; Tamai I
Reproduction; 2005 Jun; 129(6):729-36. PubMed ID: 15923388
[TBL] [Abstract][Full Text] [Related]
32. Possible involvement of cationic-drug sensitive transport systems in the blood-to-brain influx and brain-to-blood efflux of amantadine across the blood-brain barrier.
Suzuki T; Fukami T; Tomono K
Biopharm Drug Dispos; 2015 Mar; 36(2):126-37. PubMed ID: 25410756
[TBL] [Abstract][Full Text] [Related]
33. Transport of organic cations across the blood-testis barrier.
Maeda T; Goto A; Kobayashi D; Tamai I
Mol Pharm; 2007; 4(4):600-7. PubMed ID: 17616214
[TBL] [Abstract][Full Text] [Related]
34. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter.
Wu X; Huang W; Prasad PD; Seth P; Rajan DP; Leibach FH; Chen J; Conway SJ; Ganapathy V
J Pharmacol Exp Ther; 1999 Sep; 290(3):1482-92. PubMed ID: 10454528
[TBL] [Abstract][Full Text] [Related]
35. Transport of prostaglandin E1 across the blood-brain barrier in rats.
Taogoshi T; Nomura A; Murakami T; Nagai J; Takano M
J Pharm Pharmacol; 2005 Jan; 57(1):61-6. PubMed ID: 15638994
[TBL] [Abstract][Full Text] [Related]
36. Contribution of organic anion transporter 3 (Slc22a8) to the elimination of p-aminohippuric acid and benzylpenicillin across the blood-brain barrier.
Kikuchi R; Kusuhara H; Sugiyama D; Sugiyama Y
J Pharmacol Exp Ther; 2003 Jul; 306(1):51-8. PubMed ID: 12684544
[TBL] [Abstract][Full Text] [Related]
37. Functional expression of the organic cation/carnitine transporter 2 in rat astrocytes.
Inazu M; Takeda H; Maehara K; Miyashita K; Tomoda A; Matsumiya T
J Neurochem; 2006 Apr; 97(2):424-34. PubMed ID: 16539668
[TBL] [Abstract][Full Text] [Related]
38. The neurotoxin 1-methyl-4-phenylpyridinium is a substrate for the canalicular organic cation/H+ exchanger.
Moseley RH; Zugger LJ; Van Dyke RW
J Pharmacol Exp Ther; 1997 Apr; 281(1):34-40. PubMed ID: 9103477
[TBL] [Abstract][Full Text] [Related]
39. The blood-cerebrospinal fluid barrier is a major pathway of cerebral creatinine clearance: involvement of transporter-mediated process.
Tachikawa M; Kasai Y; Takahashi M; Fujinawa J; Kitaichi K; Terasaki T; Hosoya K
J Neurochem; 2008 Oct; 107(2):432-42. PubMed ID: 18752646
[TBL] [Abstract][Full Text] [Related]
40. Cellular localization of the organic cation transporters, OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP transport across the blood-brain barrier and MPTP-induced dopaminergic toxicity in rodents.
Lin CJ; Tai Y; Huang MT; Tsai YF; Hsu HJ; Tzen KY; Liou HH
J Neurochem; 2010 Aug; 114(3):717-27. PubMed ID: 20477935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
